Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zostavax Safety and Immunogenicity in Healthy Taiwanese Adults
NCT00444860Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2007
- Primary completion
- May 2007
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 3 trial of varicella virus vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Mar 2007; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00444860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444860.